Risk-Adapted Treatment for Low- and Intermediate-Risk Acute Promyelocytic Leukemia
In: Clinical lymphoma, myeloma & leukemia r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname; (2010)
Online
unknown
Zugriff:
The clinical integration of risk-tailored therapies for patients with acute promyelocytic leukemia (APL) has become a standard treatment approach in recent years. In this article, we will review the risk-adapted strategies designed to treat patients with white blood cell counts 40 x 10(9)/L (low risk), or platelet counts
Titel: |
Risk-Adapted Treatment for Low- and Intermediate-Risk Acute Promyelocytic Leukemia
|
---|---|
Autor/in / Beteiligte Person: | Montesinos, Pau ; Sanz, Miguel A. |
Link: | |
Quelle: | Clinical lymphoma, myeloma & leukemia r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname; (2010) |
Veröffentlichung: | CIG MEDIA GROUP, LP, 2010 |
Medientyp: | unknown |
ISSN: | 2152-2650 (print) |
Schlagwort: |
|
Sonstiges: |
|